Rassol Laleau

Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.

E. K. Maloney, J. Pinkas, Y. Setiady, 2017, Bioconjugate chemistry.

Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy

Greg M. Thurber, J. Pinkas, Y. Setiady, 2020, Molecular Cancer Therapeutics.

Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation.

E. K. Maloney, T. Keating, R. Chari, 2019, Bioconjugate chemistry.

Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.

J. Pinkas, T. Keating, R. Chari, 2016, Bioconjugate chemistry.

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells.

T. Chittenden, J. Pinkas, Y. Setiady, 2018, Blood advances.